pharmaphorum April 3, 2024
Phil Taylor

The FDA has cleared an artificial intelligence algorithm that can detect signs of heart failure in seconds using a digital stethoscope during a standard physical exam.

The algorithm was developed by digital stethoscope maker Eko Health in collaboration with the Mayo Clinic. It looks for low ejection fraction (EF), a reduction in outflow of blood from the heart to the aorta, which is present in approximately 50% of heart failure cases.

If LVEF is 40% or less a patient is considered to have heart failure with reduced ejection fraction (HFrEF), sometimes known as systolic heart failure, which generally has to be diagnosed in a hospital setting.

The Low EF AI means that some cases of heart failure could be spotted...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Digital Health, FDA, Govt Agencies, Patient / Consumer, Provider, Technology
OpenAI CPO: ChatGPT to Become Agentic in 2025
Report: Anthropic’s Annualized Revenue Reaches $1.4 Billion
OpenAI Launches New Tools for Building AI Agents
AI And Platforms Challenge A Key Management Theory. Again.
Salesforce pledges to invest $1 billion in Singapore over five years in AI push

Share This Article